Atlas Trials

The Effects of Orexin Antagonism on Fear Extinction in PTSD

Clinical trial NCT06788522 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06788522
Sponsor
VA Office of Research and Development
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
InsomniaPTSD
Start date
2026-06-01
Primary completion
2032-03-01
Enrollment
40120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.